Khan Bilal Arshad's Form 4 filing
SpyGlass Pharma, Inc. (SGP) · filed Feb 11, 2026
- Accession no.
- 0002108044-26-000006
- Filed
- Feb 11, 2026
- Trade date
- Feb 9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khan Bilal ArshadCIK 0002108044 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Common Stock | PPurchaseAcquired | +20,000 | $16.00 | +$320,000 | 25,450 | Direct | |
| Feb 9, 2026 | Common Stock | PPurchaseAcquired | +115,000 | $16.00 | +$1,840,000 | 251,427 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.